investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A new cellular immunotherapy to treat acute myeloid leukemia

Li Zhang

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)

Li Zhang

University Health Network

Toronto, Canada

University of California, San Francisco

San Francisco, United States

University of Toronto

Toronto, Canada

Related projects

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Leukaemia

Pathology Hematology and hematologic malignancies

Breanne Landry

A New Approach for Acute Myeloid Leukemia Treatment: siRNA Nanoparticles to Turn-Off Infinite Proliferation and Evasion of Apoptosis

Leukaemia

Xiaoyan Jiang

Targeting Drug-Insensitive CML Stem Cells with Combination Therapy of New ABL and PP2A Inhibitors

Leukaemia

Irving L. Weissman

HSC Diversity, in aging, ontogeny, and transformation

Leukaemia

Alan Rein

Retrovirus Assembly and Maturation – Rockville

Leukaemia

Hematology and hematologic malignancies Pathology

Omar Abdel-Wahab

Role of ASXL1 mutations in myeloid malignancies

Leukaemia

Scott Davis

Exposures from Chernobyl

Thyroid Leukaemia Breast

Radiation Oncology Pediatric oncology or childhood cancer

Catherine Ju-Ying Wu

Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Monica J Justice

The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms

Leukaemia

Hematology and hematologic malignancies Pathology